Publications by authors named "Shlomo Bulvik"

Claim this Profile
B
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Yishai Ofran, Michal Hayun, Ronit Leiba, Tsila Zuckerman, Netanel Horowitz, Shlomo Bulvik

Am J Hematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.
Chezi Ganzel, Ory Rouvio, Irit Avivi, Hila Magen, Osnat Jarchowsky, Shlomo Bulvik

Leuk Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.
Yishai Ofran, Ronit Leiba, Chezi Ganzel, Revital Saban, Moshe Gatt, Shlomo Bulvik

Am J Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice.
Martin H Ellis, Noa Lavi, Elena Mishchenko, Najib Dally, David Lavie, Shlomo Bulvik

Leuk Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.
Yael Porat, Efrat Assa-Kunik, Michael Belkin, Michael Krakovsky, Itschak Lamensdorf, Shlomo Bulvik

Diabetes Metab Res Rev· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
Eitan Lilo, Shane Wald-Altman, Leonardo J Solmesky, Keren Ben Yaakov, Noga Gershoni-Emek, Shlomo Bulvik

Hum Mol Genet· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immune globulin in autoimmune and inflammatory diseases.
Zvi Shimoni, Shlomo Bulvik, Paul Froom

N Engl J Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis.
Henny Nachmany, Shane Wald, Michal Abekasis, Shlomo Bulvik, Miguel Weil

Dis Markers· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy.
Zvi Shimoni, Hanna Bin, Shlomo Bulvik, Mark Niven, Rawi Hazzan

Clin Pract· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis.
Akop Seksenyan, Noga Ron-Harel, David Azoulay, Liora Cahalon, Michal Cardon, Shlomo Bulvik

J Cell Mol Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules.
Leonardo Solmesky, Sharon Lefler, Jasmine Jacob-Hirsch, Shlomo Bulvik, Gideon Rechavi

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone morphogenetic protein signaling is involved in human mesenchymal stem cell survival in serum-free medium.
Leonardo J Solmesky, Michal Abekasis, Shlomo Bulvik, Miguel Weil

Stem Cells Dev· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
Ofer Sadan, Merav Bahat-Stromza, Yael Barhum, Yossef S Levy, Anat Pisnevsky, Shlomo Bulvik

Stem Cells Dev· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.
Merav Bahat-Stroomza, Yael Barhum, Yossef S Levy, Olga Karpov, Shlomo Bulvik

J Mol Neurosci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells.
Ran Barzilay, Tali Ben-Zur, Shlomo Bulvik, Eldad Melamed, Daniel Offen

Stem Cells Dev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols.
Ran Barzilay, Inna Kan, Tali Ben-Zur, Shlomo Bulvik, Eldad Melamed

Stem Cells Dev· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
Ohad Karnieli, Yael Izhar-Prato, Shlomo Bulvik, Shimon Efrat

Stem Cells· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression.
Inna Kan, Tali Ben-Zur, Yael Barhum, Yossef S Levy, Alex Burstein, Shlomo Bulvik

Neurosci Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current clinical uses of intravenous immunoglobulin.
Zvi Shimoni, Shlomo Bulvik, Mark Niveni

Clin Med (Lond)· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mesenchymal stem cells express neural genes, suggesting a neural predisposition.
Netta R Blondheim, Yossef S Levy, Tali Ben-Zur, Alex Burshtein, Tirza Cherlow, Shlomo Bulvik

Stem Cells Dev· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis